Other disease associations with non-alcoholic fatty liver disease (NAFLD)
- PMID: 12406445
- DOI: 10.1053/bega.2002.0330
Other disease associations with non-alcoholic fatty liver disease (NAFLD)
Abstract
Non-alcoholic fatty liver disease (NAFLD) is usually seen in middle-aged women with obesity, non-insulin-dependent diabetes mellitus and/or hyperlipidaemia. NAFLD has also been associated with other conditions. Surgical procedures to treat obesity such as jejunoileal bypass and gastroplasty as well as massive small bowel resection have been associated with NAFLD. Mechanisms such as rapid weight loss, certain nutritional deficiencies and bacterial overgrowth have been proposed. Other nutritional conditions such as extreme malnutrition and total parenteral nutrition can also cause NASH. This can be due to abnormal glucose and fat metabolism, deficiencies like carnitine, essential fatty acid and choline or, in the case of parenteral nutrition, excess of calories, glucose or lipids. Several drugs have also been implicated as well as some inborn errors of metabolism and, more rarely, other diseases.
Similar articles
-
Metabolic and nutritional considerations in nonalcoholic fatty liver.Hepatology. 2000 Jul;32(1):3-10. doi: 10.1053/jhep.2000.8978. Hepatology. 2000. PMID: 10869282 Review. No abstract available.
-
Role of diet and nutritional management in non-alcoholic fatty liver disease.J Gastroenterol Hepatol. 2013 Dec;28 Suppl 4:81-7. doi: 10.1111/jgh.12244. J Gastroenterol Hepatol. 2013. PMID: 24251710
-
Review article: current management of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis.Aliment Pharmacol Ther. 2008 Jul;28(1):2-12. doi: 10.1111/j.1365-2036.2008.03710.x. Epub 2008 Apr 11. Aliment Pharmacol Ther. 2008. PMID: 18410557 Review.
-
The use of statins alone, or in combination with pioglitazone and other drugs, for the treatment of non-alcoholic fatty liver disease/non-alcoholic steatohepatitis and related cardiovascular risk. An Expert Panel Statement.Metabolism. 2017 Jun;71:17-32. doi: 10.1016/j.metabol.2017.02.014. Epub 2017 Mar 4. Metabolism. 2017. PMID: 28521870 Review.
-
Murine models provide insight to the development of non-alcoholic fatty liver disease.Nutr Res Rev. 2015 Dec;28(2):133-142. doi: 10.1017/S0954422415000128. Epub 2015 Oct 23. Nutr Res Rev. 2015. PMID: 26494024
Cited by
-
Exploring the Multifaceted Landscape of MASLD: A Comprehensive Synthesis of Recent Studies, from Pathophysiology to Organoids and Beyond.Biomedicines. 2024 Feb 8;12(2):397. doi: 10.3390/biomedicines12020397. Biomedicines. 2024. PMID: 38397999 Free PMC article. Review.
-
Bariatric Surgery and Inflammatory Bowel Disease: National Trends and Outcomes Associated with Procedural Sleeve Gastrectomy vs Historical Bariatric Surgery Among US Hospitalized Patients 2009-2020.Obes Surg. 2023 Nov;33(11):3472-3486. doi: 10.1007/s11695-023-06833-7. Epub 2023 Oct 7. Obes Surg. 2023. PMID: 37804470 Free PMC article.
-
NAFLD in normal weight individuals.Diabetol Metab Syndr. 2022 Mar 24;14(1):45. doi: 10.1186/s13098-022-00814-z. Diabetol Metab Syndr. 2022. PMID: 35331317 Free PMC article. Review.
-
Morphological, dynamic and functional characteristics of liver pseudolesions and benign lesions.Radiol Med. 2022 Feb;127(2):129-144. doi: 10.1007/s11547-022-01449-w. Epub 2022 Jan 13. Radiol Med. 2022. PMID: 35028886 Review.
-
Primary Versus Secondary NAFLD: Perspective on Advanced Fibrosis.J Clin Exp Hepatol. 2021 Sep-Oct;11(5):557-564. doi: 10.1016/j.jceh.2020.12.009. Epub 2020 Dec 31. J Clin Exp Hepatol. 2021. PMID: 34511816 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
